PepperLime Health Acquisi... (PEPLU)
PepperLime Health Acquisition Statistics
Share Statistics
PepperLime Health Acquisition has - shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.38M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 52.42 and the forward PE ratio is null. PepperLime Health Acquisition's PEG ratio is -0.05.
| PE Ratio | 52.42 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 1.03 |
| P/FCF Ratio | -397.87 |
| PEG Ratio | -0.05 |
Enterprise Valuation
PepperLime Health Acquisition has an Enterprise Value (EV) of 172.68M.
| EV / Sales | 0 |
| EV / EBITDA | -127.59 |
| EV / EBIT | -395.83 |
| EV / FCF | -395.83 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.
| Current Ratio | 1.78 |
| Quick Ratio | 1.78 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0.61 |
Financial Efficiency
Return on Equity is 1.96% and Return on Invested Capital is -2.44%.
| Return on Equity | 1.96% |
| Return on Assets | 1.89% |
| Return on Invested Capital | -2.44% |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.22M |
| Effective Tax Rate | -204.42% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0.01, so PepperLime Health Acquisition's price volatility has been higher than the market average.
| Beta | 0.01 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 10.78 |
| 200-Day Moving Average | 10.48 |
| Relative Strength Index (RSI) | 97.06 |
| Average Volume (20 Days) | 1 |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -1.35M |
| Net Income | 3.31M |
| EBITDA | -1.35M |
| EBIT | -1.14M |
| Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 891.15K in cash and 0 in debt, giving a net cash position of 891.15K.
| Cash & Cash Equivalents | 891.15K |
| Total Debt | 0 |
| Net Cash | 891.15K |
| Retained Earnings | -5.4M |
| Total Assets | 9.07M |
| Working Capital | -315K |
Cash Flow
In the last 12 months, operating cash flow was -436.25K and capital expenditures 0, giving a free cash flow of -436.25K.
| Operating Cash Flow | -436.25K |
| Capital Expenditures | 0 |
| Free Cash Flow | -436.25K |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PEPLU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.91% |
| FCF Yield | -0.25% |
Analyst Forecast
Currently there are no analyst rating for PEPLU.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 3.45 |
| Piotroski F-Score | 3 |